Price Transparency & Cost Containment Strategies
Improving Employee Health and Your Bottom Line
Brady Kahl, Strategic Analytics Advisor Brandon Collins, Advisor
Price Transparency & Cost Containment Strategies Improving - - PowerPoint PPT Presentation
Price Transparency & Cost Containment Strategies Improving Employee Health and Your Bottom Line Brady Kahl, Strategic Analytics Advisor Brandon Collins, Advisor Price Transparency Price-Disclosure Requirement & Consumerism Tools
Brady Kahl, Strategic Analytics Advisor Brandon Collins, Advisor
Disease state and population health management
Beacon Summit Platform Summit Plus
Expert Opinions Complex case review with world-class experts
✓ ✓ ✓
Office Visits We find and schedule high-quality local care for your members’ complex needs
✓ ✓ ✓
Treatment Decision Support Consult with our staff clinicians quickly by video or phone
✓ ✓ ✓
Match Platform Data-enabled matching with high-quality local providers, facilities, and procedures
✓ ✓
Benefits Routing Connect to relevant benefits with intelligent routing
✓ ✓
Plan Details Make sense of deductibles, out-of-pocket expenses, and HRA/HSA balances
✓
Advocacy High-touch support to remove any obstacle, including medical claims issues and care logistics
✓
Treatment Decision Support:
Access staff physicians for answers or triage quickly within 24 hours
Office Visits:
Find best local experts for member needs
Expert Opinion:
Connect with experts for
treatment
Triage Education Physician Matching Cost Efficiency Priority Access Fast Decision Support Diagnosis & Treatment Plan Unnecessary Care Avoidance Rx & Treatment Support Expertise
9 billion clinical data points measured and new
data incorporated monthly
Selected states CMS, medical societies, hospitals, group practices, additional states State APCDs and commercial data vendors Grand Rounds proprietary data
2011 2012 2013 2014 2015 2016
Availability of Provider-Level Data Grand Rounds Analysis
> 96% of MDs rated based on clinical quality Background Data
Performance Data
Quality Factors Include:
Grand Rounds expert physicians
(0.3%)
Grand Rounds office visits physicians
(10%)
923,000 U.S. physicians
Every other physician
90%
Without Guidance, Members are Unlikely to Find the Best Care
“Average Member” Analysis: Provider quality is defined here based on quality algorithm outputs for a representative member of commercially insured populations. In practice, quality ratings vary for individuals based on each member’s clinical profile.
Physician Quality 0-19% (Lowest) 20-39% 40-59% 60-79% 80-99% (Highest)
Physician Quality 0-19% (Lowest) 20-39% 40-59% 60-79% 80-99% (Highest)
45%
improvement w/out disruption
Top quality physicians achieve:
“Average Member” Analysis: Provider quality is defined here based on quality algorithm outputs for a representative member of commercially insured populations. In practice, quality ratings vary for individuals based on each member’s clinical profile.
Average quality of an actual national network optimized for quality
change in diagnosis or treatment recommendations
saved on average per converted in-person office visit
discontinuation of opioids in
saved on average per expert
saved on average per expert opinion
cancellation of unnecessary procedures
140,000 Lives 1,000+ Renewals 30% - Largest increase in SL premium 0 New lasers <1% Members hit max 120 Employees 546 Members 97% Renewal ratio $185m SL premium
Remember the rules in group size counting!
Chamber & IndyChamber
eligible
reimbursement for outpatient services
Health insurer Cigna buying Express Scripts for $52 billion Anthem breaks up with Express Scripts, to start own drug plan IngenioRx (CVS platform) CVS buying Aetna for 67 billion, shaking up health care industry Express Scripts leader wants Anthem to stay client despite $15 billion suit
Americans spend on prescription drugs in 2016
pending patents and FDA approvals are for specialty drugs
Employer plan spending is
Wholesale pricing for pharmacy drugs has increased by
22.1% 20.5% 29.7%
Specialty Cost Drivers
Inflammatory Diabetes Oncology 55% 45% New Oncology Drugs First-in-class
Pipeline Dominated by Oncology Anti-Inflammatory Drugs in Specialty Pipeline
34 18 7 Total Anti-Inflammatory Drug Potential Approvals New Drugs Potential Biosimilars
Americans have difficulty affording their medication(s)
transparency on drug pricing from manufacturers
drug; 85% are filled as generics
Diabetes has the highest per member per year spending of
bcollins@firstpersonadvisors.com https://www.linkedin.com/in/brand
bkahl@firstpersonadvisors.com https://www.linkedin.com/in/brady